Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12614000715673Phase 3Completed
Phase 3, open-label trial of triptorelin in infertility (2 arms), sponsored by Hôpital Femme Mère Enfant. Primary endpoint: Ongoing pregnancy rate. Started Oct 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12614000715673.